Some evidence suggests that APP might be linked to hyperprolactinaemia and weight gain, but again the evidence is inconclusive as some studies also find weight loss when comparing patients on APP with monotherapy (Gallego, Nielsen, De Hert, Kane, & Correll, 2012). The gene discussed is APP; the disease is Increased circulating prolactin concentration.